What Is The Role Of The FDA In Measures Taken By Hawaii Officials Against A CBD Company?

The Hawaii Department of Health (DOH) and Hawaii Department of Public Safety (PSD) conducted operations to execute search warrants and to embargo products at several retail stores including a CBD dispensary in Honolulu, reported Marijuana Moment.

“We want to make sure businesses fully understand the consequences they face when they knowingly disregard the law,” said Jordan Lowe, PSD deputy director for law enforcement.

The FDA partnered with Hawaii law enforcement in the operation that led to the arrest of two people associated with a cannabis business, saying the suspects violated state drug laws and promoted a harmful drug. Also, the remaining products in the two shops were seized.

“We want to make clear that unlawful activity will not be tolerated,” said Lori Nagatoshi of the DOH Food and Drug Branch. “We thank our law enforcement partners who share our mission in protecting Hawaii residents.”

The FDA’s Office of Regulatory Affairs (ORA) boasted on Twitter last week  that the federal-state partnership resulted in enforcement action when it “surveilled retail shops in Hawaii’s Chinatown, including a CBD dispensary.”

“As a result, law enforcement & [the state Department of Health] embargoed CBD products and arrested two people suspected of promoting harmful and/or detrimental drugs,” FDA said.

“This type of operation is unique and is an example of our efforts to expand partnership opportunities with the states in areas of mutual public health and law enforcement priorities,” an FDA spokesperson said. “The FDA is committed to partnering with states and has entered into a formal partnership agreement with the state of Hawai’i to coordinate efforts in support of our shared public health missions.”

Both individuals arrested have been released pending investigation.

When it comes to CBD, the FDA often takes enforcement action, such as sending warning letters to companies that make misleading medical claims about their products. However, FDA’s involvement, in this case, seems to exceed its competence.

Photo: Courtesy of Add Weed On Unsplash

Posted In: Food and Drug AdministrationHawaiʻi Department of Public SafetyJordan LoweLori NagatoshiThe Hawaiʻi Department of HealthCannabisNewsFDAMarkets

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.